نتائج البحث 301-310 من 18709 لعملية البحث عن LL-37
... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A study to create and analyze a comprehensive longitudinal resource ...
... 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System ...
Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...
... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A Multimodal Monitoring (MMM) Computer to Detect Physiologic Trends ...
Accessed March 2, 2025. Kobayashi S, et al Analysis of adverse events of cholinesterase inhibitors and NMDA receptor antagonists on arrhythmias using the ...
... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...
... 2 or 3 meningioma as measured by 6-month PFS rate. Minnesota Spinal Cord Injury Data Network. Rochester, Minn. This is a study to generate feasibilty data ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.